Unitedhealth: Invesco Ltd.’s Biggest Healthcare Stock Holding in Q3

Wall St. Watchdog reveals information regarding Invesco Ltd.’s top holdings in the Healthcare sector for the quarter ending September 30th, 2011. The firm held 314 stocks in the Healthcare sector at the end of the quarter with an aggregate market value of $15.274 billion.

  • Unitedhealth Group Inc. (NYSE:UNH): On 06/30/2011, Invesco Ltd. reported holding 26,717,325 shares with a market value of $1,378,079,672. This comprised 0.75% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 27,847,476 shares with a market value of $1,284,325,563. This comprised 0.83% of the total portfolio. The net change in shares for this position over the two quarters is 1,130,151. About Company: UnitedHealth Group Incorporated owns and manages organized health systems in the United States and internationally. The Company provides employers products and resources to plan and administer employee benefit programs. UnitedHealth also serves the health needs of older Americans, provides specialized care services, and provides health care information and research to providers and payers.
  • Pfizer Inc. (NYSE:PFE): On 06/30/2011, Invesco Ltd. reported holding 75,247,581 shares with a market value of $1,550,100,197. This comprised 0.85% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 70,413,811 shares with a market value of $1,244,916,200. This comprised 0.81% of the total portfolio. The net change in shares for this position over the two quarters is -4,833,770. About Company: Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company’s products include prescription pharmaceuticals, non-prescription self-medications, and animal health products such as anti-infective medicines and vaccines.
  • Bristol-myers Squibb Company (NYSE:BMY): On 06/30/2011, Invesco Ltd. reported holding 28,559,927 shares with a market value of $827,095,460. This comprised 0.45% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 27,327,028 shares with a market value of $857,522,116. This comprised 0.56% of the total portfolio. The net change in shares for this position over the two quarters is -1,232,899. About Company: Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, manufactures and sells pharmaceutical and nutritional products. The Company’s products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection and psychiatric disorders.
  • Merck & Co. Inc. (NYSE:MRK): On 06/30/2011, Invesco Ltd. reported holding 23,305,502 shares with a market value of $822,451,187. This comprised 0.45% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 23,311,621 shares with a market value of $762,290,024. This comprised 0.49% of the total portfolio. The net change in shares for this position over the two quarters is 6,119. About Company: Merck & Co., Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a broad range of human and animal health products. Merck’s products include a treatment for elevated cholesterol, a treatment for male pattern hair loss, a preventive treatment for osteoporosis, a treatment for hypertension, and a treatment for allergic rhinitis.
  • Johnson & Johnson (NYSE:JNJ): On 06/30/2011, Invesco Ltd. reported holding 11,461,157 shares with a market value of $762,396,125. This comprised 0.42% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 11,809,091 shares with a market value of $752,120,990. This comprised 0.49% of the total portfolio. The net change in shares for this position over the two quarters is 347,934. About Company: Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
  • Teva Pharmaceutical Industries Limited (NASDAQ:TEVA): On 06/30/2011, Invesco Ltd. reported holding 18,809,034 shares with a market value of $906,971,642. This comprised 0.5% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 18,975,257 shares with a market value of $706,259,089. This comprised 0.46% of the total portfolio. The net change in shares for this position over the two quarters is 166,223. About Company: Teva Pharmaceutical Industries Ltd. develops, manufactures and markets generic and branded human pharmaceuticals and active pharmaceutical ingredients. The Company produces antibiotics, oncological products, Alpha D3 for treatment of post-menopausal bone loss in women and Copaxone for treatment of multiple sclerosis. Teva develops novel drugs for diseases of the central nervous system.
  • Amgen Inc. (NASDAQ:AMGN): On 06/30/2011, Invesco Ltd. reported holding 13,072,766 shares with a market value of $762,795,876. This comprised 0.42% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 12,741,457 shares with a market value of $700,270,465. This comprised 0.45% of the total portfolio. The net change in shares for this position over the two quarters is -331,309. About Company: Amgen Inc. discovers, develops, manufactures, and markets human therapeutics based on cellular and molecular biology. The Company focuses its research on secreted protein and small molecule therapeutics, with particular emphasis on neuroscience and cancer. Amgen concentrates on the areas of hematology, cancer, infectious disease, endocrinology, neurobiology, and inflammation.
  • Gilead Sciences Inc. (NASDAQ:GILD): On 06/30/2011, Invesco Ltd. reported holding 16,942,385 shares with a market value of $701,584,160. This comprised 0.38% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 16,761,731 shares with a market value of $650,355,150. This comprised 0.42% of the total portfolio. The net change in shares for this position over the two quarters is -180,654. About Company: Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops, and commercializes therapeutics to advance the care of patients suffering from life-threatening diseases. The Company’s primary arees of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
  • Wellpoint Inc. (NYSE:WLP): On 06/30/2011, Invesco Ltd. reported holding 7,268,352 shares with a market value of $572,528,063. This comprised 0.31% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 7,377,758 shares with a market value of $481,620,033. This comprised 0.31% of the total portfolio. The net change in shares for this position over the two quarters is 109,406. About Company: WellPoint Inc. is a health benefits company. The Company provides health benefits, dental and vision benefits, pharmacy benefits, life insurance, and life and disability insurance benefits. WellPoint operations include Blue Cross and Blue Shield plans.
  • Abbott Laboratories (NYSE:ABT): On 06/30/2011, Invesco Ltd. reported holding 9,561,275 shares with a market value of $503,114,280. This comprised 0.27% of the total portfolio. On 09/30/2011, Invesco Ltd. reported holding 9,268,977 shares with a market value of $474,015,478. This comprised 0.31% of the total portfolio. The net change in shares for this position over the two quarters is -292,298. About Company: Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.

(Note: Data regarding Invesco Ltd.’s stock holdings are sourced from whalewisdom.com. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet